EA200100801A1 - THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING - Google Patents

THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING

Info

Publication number
EA200100801A1
EA200100801A1 EA200100801A EA200100801A EA200100801A1 EA 200100801 A1 EA200100801 A1 EA 200100801A1 EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A EA200100801 A EA 200100801A EA 200100801 A1 EA200100801 A1 EA 200100801A1
Authority
EA
Eurasian Patent Office
Prior art keywords
manufacture
treatment
pharmaceutical composition
nazal
uterine bleeding
Prior art date
Application number
EA200100801A
Other languages
Russian (ru)
Inventor
Яннис Тсудеро
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200100801A1 publication Critical patent/EA200100801A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению полового гормона при изготовлении фармацевтической композиции, пригодной для назального введения и предназначенной для лечения нежелательных маточных кровотечений у женщин.Отчет о международном поиске был опубликован 2001.04.26.The present invention relates to the use of sex hormone in the manufacture of a pharmaceutical composition suitable for nasal administration and intended for the treatment of unwanted uterine bleeding in women. The international search report was published 2001.04.26.

EA200100801A 1999-03-31 2000-03-30 THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING EA200100801A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (en) 1999-03-31 1999-03-31 Treating undesirable uterine bleeding, e.g. as side-effect of hormone therapy, by intranasal administration of estradiol
PCT/FR2000/000790 WO2000059447A2 (en) 1999-03-31 2000-03-30 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding

Publications (1)

Publication Number Publication Date
EA200100801A1 true EA200100801A1 (en) 2002-04-25

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100801A EA200100801A1 (en) 1999-03-31 2000-03-30 THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING

Country Status (16)

Country Link
EP (1) EP1143978A2 (en)
JP (1) JP2002541076A (en)
KR (1) KR20010102464A (en)
CN (1) CN1346273A (en)
AU (1) AU3662300A (en)
BR (1) BR0008577A (en)
CA (1) CA2361885A1 (en)
EA (1) EA200100801A1 (en)
FR (1) FR2791572A1 (en)
HK (1) HK1044486A1 (en)
HU (1) HUP0200244A3 (en)
NO (1) NO20014022D0 (en)
NZ (1) NZ513672A (en)
PL (1) PL356767A1 (en)
WO (1) WO2000059447A2 (en)
ZA (1) ZA200106689B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (en) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
PL331357A1 (en) * 1996-07-23 1999-07-05 Pherin Pharmaceuticals Steroids as neurochemical vno stimulators for soothing the symptoms of premenstrual tension and anxiety

Also Published As

Publication number Publication date
AU3662300A (en) 2000-10-23
CA2361885A1 (en) 2000-10-12
HK1044486A1 (en) 2002-10-25
NO20014022L (en) 2001-08-17
HUP0200244A3 (en) 2003-05-28
WO2000059447A3 (en) 2001-04-26
WO2000059447A2 (en) 2000-10-12
JP2002541076A (en) 2002-12-03
NO20014022D0 (en) 2001-08-17
FR2791572A1 (en) 2000-10-06
ZA200106689B (en) 2002-11-14
NZ513672A (en) 2001-09-28
BR0008577A (en) 2002-10-01
CN1346273A (en) 2002-04-24
EP1143978A2 (en) 2001-10-17
PL356767A1 (en) 2004-07-12
KR20010102464A (en) 2001-11-15
HUP0200244A2 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
EA200201000A1 (en) HORMONE-DESTINY THERAPY
IT1252868B (en) ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE
PT1079806E (en) PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT
BRPI0113286B8 (en) substituted pyrazoles and pharmaceutical composition comprising the same.
EA200301022A1 (en) HORMONAL REPLACEMENT THERAPY
SE0100158D0 (en) Novel method and composition for local treatment of Meniere's disease and tinnitus
ATE375341T1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OR PREVENTION OF PAIN
ATE451123T1 (en) VAGINAL ADMINISTERED COMPOSITION FOR THE TREATMENT OF UTERINE DYSRHYTHMIA
KR950031060A (en) Pharmaceutical composition for the treatment of osteoporosis
EA200400731A1 (en) METHOD AND PHARMACEUTICAL COMPOSITION FOR UNEXPECTABLE CONTRACEPTION
WO2001076638A3 (en) Compositions for drug delivery
EE05259B1 (en) Use of antiprogestins for the prophylaxis and treatment of hormone dependent diseases
ATE289293T1 (en) SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE-STIMULATING HORMONE
ATE412412T1 (en) DERIVATIVES OF 3-HYDROXY-4-(CYCLYL-ALKYLAMINOALKYL)-5-PHENYL-1-PYRAZOLE AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH) FOR USE IN THE TREATMENT OF SEX HORMONAL DISEASES, SUCH AS PROSTATE OR MATERNAL CANCER
GB2368525A (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
EA200301023A1 (en) REPLACEMENT THERAPY WITH ESTROGENS
TW200501963A (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
EA200100828A1 (en) 16 HYDROXYETTRATRIENES AS ESTROGENS OF ELECTORAL ACTION
DK1343472T3 (en) Thixotropic nasal spray
EA200100801A1 (en) THE APPLICATION OF SEXUAL HORMONES IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR NAZAL INTRODUCTION INTENDED FOR THE TREATMENT OF UNDESIRABLE Uterine BLEEDING
EA200200284A1 (en) MESOPROGESTINES (PROGESTERONE RECEPTOR MODULATORS) AS A COMPONENT OF WOMEN'S CONTRACEPTIVES
EA200601089A1 (en) TRANSDERMAL DELIVERY OF HORMONES WITHOUT THE NEED TO USE AGENTS, STRENGTHENING PENETRATION
EP0902025A3 (en) Benzothiophenes for treatment of estrogen related conditions
ATE371737T1 (en) PROTEAS RESISTANT FLINT ANALOGUE
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine